Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03719430
Title APX005M, Doxorubicin, Olaratumab in Advanced Sarcoma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Columbia University
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Duarte California 91010 United States Details
Washington University School of Medicine - Siteman Cancer Center Saint Louis Missouri 63110 United States Details
Columbia University Irving Medical Center/NYP New York New York 10032 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field